Clinical Trials

Search for actively enrolling clinical trials

A three-year, multi-center, double-blind, extension study to evaluate the long-term safety and efficacy of ligelizumab in patients who completed ligelizumab’s Phase III studies in food allergy

Study ID: STU-2023-0362

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
JOHN ANDREW BIRD

Contact:

Melissa Zamudio

Melissa.Zamudio@Childrens.com

Linked In Email
scroll to top